Identifying genomic and developmental causes of adverse drug reactions in children

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.11, 2010-11, pp. : 1591-1602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Detecting Unexpected Adverse Drug Reactions in Children

By Star Kristina

Pediatric Drugs, Vol. 13, Iss. 2, 2011-04 ,pp. : 71-73

Adis International

Access to resources Recommend Favorite

Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions: Data Mining of a Spontaneous Reporting Database in Italy

By Leone Roberto

Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. : 667-675

Adis International

Access to resources Recommend Favorite

Pharmacogenomics and active surveillance for serious adverse drug reactions in children

By Loo Tenneille T Ross Colin JD Sistonen Johanna Visscher Henk Madadi Parvaz Koren Gideon Hayden Michael R Carleton Bruce C

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1269-1285

Future Medicine

Access to resources Recommend Favorite

The cost of adverse drug reactions

By Gautier Sophie Bachelet Hélène Bordet Régis Caron Jacques

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 319-326

Informa Healthcare

Access to resources Recommend Favorite

Ocular adverse drug reactions

By Fraunfelder FW

Expert Opinion on Drug Safety, Vol. 2, Iss. 4, 2003-07 ,pp. : 411-420

Informa Healthcare

Access to resources Recommend Favorite